Switzerland· 47572029
Perenterol 250, Polvere per sospensione orale
A saccharomyces boulardii product containing saccharomyces boulardii cryodesiccatus (saccharomyces boulardii cncm i-745), registered in Switzerland by Zambon Svizzera SA, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Saccharomyces boulardii is registered in 10 of 19 countries.
Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Saccharomyces boulardii · ATC A07FA02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of saccharomyces boulardii costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- Switzerland: $4.16 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Saccharomyces boulardii · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.16
The record
At a glance
Swissmedic (Switzerland)- Active substance
- saccharomyces boulardii cryodesiccatus (Saccharomyces boulardii CNCM I-745)
- Manufacturer
- Zambon Svizzera SA
- Country
- Switzerland (CH)
- ATC code
- A07FA02
- ATC class
- Saccharomyces boulardii
- Defined daily dose
- 1 g, O
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680475720295Btl 10 StkCHF 8.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A07FA02
Saccharomyces boulardii, as other registers publish it.
- BelgiumAntediar 125 mgWill Pharma
- BelgiumAntediar 250 mgWill Pharma
- United KingdomBiome Balance For those on Antibiotics 300mg capsulesLamberts Healthcare Ltd
- NorwayCodex 5 miliardiBiocodex
- PolandEnterolAllpharm Sp. z o.o. sp.k.
- PolandEnterolDelfarma Sp. z o.o.
- PolandEnterolAllpharm Sp. z o.o. sp.k.
- PolandEnterolInPharm Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d95f0133-4372-4294-9fba-c4e060a8f8d4 GET /v1/drugs/d95f0133-4372-4294-9fba-c4e060a8f8d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "saccharomyces boulardii cryodesiccatus 250 mg",
"valid_from": "1997-03-15",
"limitations": "[{\"description\":\"Zur Therapie der rekurrierenden Clostridium difficile-assoziierten Erkrankungen und zur Rezidivprophylaxe der rekurrierenden Clostridium difficile-assoziierten Erkrankungen sowie in jenen Fällen, bei denen aufgrund des Allgemeinzustandes eine schwere Antibiotika-induzierte Diarrhöe nicht auszuschliessen ist.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"}]",
"galenic_form": "Plv 250 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1997-03-15",
"self_retention_pct": 10
}See everything about saccharomyces boulardii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.